Literature for RO4929097 (A22.001 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2012
1. Kolb,E.A., Gorlick,R., Keir,S.T., Maris,J.M., Lock,R., Carol,H., Kurmasheva,R.T., Reynolds,C.P., Kang,M.H., Wu,J., Houghton,P.J. and Smith,M.A.
   Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a gamma-secretase inhibitor targeting notch signaling
   Pediatr Blood Cancer58, 815-818. PubMed  Europe PubMed DOI  I
2009
2. Luistro,L., He,W., Smith,M., Packman,K., Vilenchik,M., Carvajal,D., Roberts,J., Cai,J., Berkofsky-Fessler,W., Hilton,H., Linn,M., Flohr,A., Jakob-Rotne,R., Jacobsen,H., Glenn,K., Heimbrook,D. and Boylan,J.F.
   Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties
   Cancer Res69, 7672-7680. PubMed  Europe PubMed DOI  I